WallStreetZenWallStreetZen

NASDAQ: PRAX
Praxis Precision Medicines Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PRAX

Based on 5 analysts offering 12 month price targets for Praxis Precision Medicines Inc

Min Forecast
$73.00+93.94%
Avg Forecast
$91.80+143.89%
Max Forecast
$111.00+194.9%

Should I buy or sell PRAX stock?

Based on 5 analysts offering ratings for Praxis Precision Medicines Inc.

Strong Buy
Strong Buy
2 analysts 40%
Buy
3 analysts 60%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although PRAX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates PRAX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their PRAX stock forecasts and price targets.

PRAX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-08
lockedlocked$00.00+00.00%2025-03-03
lockedlocked$00.00+00.00%2025-03-03
lockedlocked$00.00+00.00%2025-03-03
lockedlocked$00.00+00.00%2025-02-11

1 of 1

Forecast return on equity

Is PRAX forecast to generate an efficient return?

Company
-33.1%
Industry
142.9%
Market
80.27%
PRAX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PRAX forecast to generate an efficient return on assets?

Company
-30.52%
Industry
35.65%
PRAX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PRAX earnings per share forecast

What is PRAX's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$12.77
Avg 2 year Forecast
-$12.83
Avg 3 year Forecast
-$10.67

PRAX revenue forecast

What is PRAX's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$4.2M-51.08%
Avg 2 year Forecast
$19.6M+129.28%
Avg 3 year Forecast
$81.6M+853.99%
PRAX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PRAX revenue growth forecast

How is PRAX forecast to perform vs Biotechnology companies and vs the US market?

Company
105.52%
Industry
64.17%
Market
10.07%
PRAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PRAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PRAX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PRAX$37.64$91.80+143.89%Strong Buy
OCS$17.40$33.67+93.49%Strong Buy
NUVB$2.25$9.00+300.00%Strong Buy
IMNM$8.79$26.40+200.34%Strong Buy
REPL$9.78$21.50+119.84%Strong Buy
View Top Biotech Stocks

Praxis Precision Medicines Stock Forecast FAQ

Is Praxis Precision Medicines Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: PRAX) stock is to Strong Buy PRAX stock.

Out of 5 analysts, 2 (40%) are recommending PRAX as a Strong Buy, 3 (60%) are recommending PRAX as a Buy, 0 (0%) are recommending PRAX as a Hold, 0 (0%) are recommending PRAX as a Sell, and 0 (0%) are recommending PRAX as a Strong Sell.

If you're new to stock investing, here's how to buy Praxis Precision Medicines stock.

What is PRAX's earnings growth forecast for 2025-2027?

(NASDAQ: PRAX) Praxis Precision Medicines's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.59%.

Praxis Precision Medicines's earnings in 2025 is -$182,819,000.On average, 8 Wall Street analysts forecast PRAX's earnings for 2025 to be -$257,400,017, with the lowest PRAX earnings forecast at -$305,069,973, and the highest PRAX earnings forecast at -$223,735,455. On average, 7 Wall Street analysts forecast PRAX's earnings for 2026 to be -$258,603,763, with the lowest PRAX earnings forecast at -$382,900,118, and the highest PRAX earnings forecast at -$170,581,095.

In 2027, PRAX is forecast to generate -$215,206,400 in earnings, with the lowest earnings forecast at -$315,353,230 and the highest earnings forecast at -$134,085,613.

What is PRAX's revenue growth forecast for 2025-2027?

(NASDAQ: PRAX) Praxis Precision Medicines's forecast annual revenue growth rate of 105.52% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.17%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.07%.

Praxis Precision Medicines's revenue in 2025 is $8,553,000.On average, 3 Wall Street analysts forecast PRAX's revenue for 2025 to be $84,363,038, with the lowest PRAX revenue forecast at $40,326,500, and the highest PRAX revenue forecast at $172,456,277. On average, 4 Wall Street analysts forecast PRAX's revenue for 2026 to be $395,401,333, with the lowest PRAX revenue forecast at $16,130,600, and the highest PRAX revenue forecast at $1,352,752,443.

In 2027, PRAX is forecast to generate $1,645,220,384 in revenue, with the lowest revenue forecast at $115,132,158 and the highest revenue forecast at $3,576,355,653.

What is PRAX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: PRAX) forecast ROA is -30.52%, which is lower than the forecast US Biotechnology industry average of 35.65%.

What is PRAX's Price Target?

According to 5 Wall Street analysts that have issued a 1 year PRAX price target, the average PRAX price target is $91.80, with the highest PRAX stock price forecast at $111.00 and the lowest PRAX stock price forecast at $73.00.

On average, Wall Street analysts predict that Praxis Precision Medicines's share price could reach $91.80 by Apr 8, 2026. The average Praxis Precision Medicines stock price prediction forecasts a potential upside of 143.89% from the current PRAX share price of $37.64.

What is PRAX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: PRAX) Praxis Precision Medicines's current Earnings Per Share (EPS) is -$10.21. On average, analysts forecast that PRAX's EPS will be -$12.77 for 2025, with the lowest EPS forecast at -$15.13, and the highest EPS forecast at -$11.10. On average, analysts forecast that PRAX's EPS will be -$12.83 for 2026, with the lowest EPS forecast at -$18.99, and the highest EPS forecast at -$8.46. In 2027, PRAX's EPS is forecast to hit -$10.67 (min: -$15.64, max: -$6.65).

What is PRAX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: PRAX) forecast ROE is -33.1%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.